United Kingdom· GB-APID-235311000001105
Ovysmen 500microgram/35microgram tablets
A medicinal product containing ethinylestradiol + norethisterone, registered in United Kingdom by Janssen-Cilag Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ethinylestradiol + Norethisterone
- Manufacturer
- Janssen-Cilag Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5012946030169
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ethinylestradiol + norethisterone in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/84719a40-754a-44e1-b15a-bec658f9abc1 GET /v1/drugs/84719a40-754a-44e1-b15a-bec658f9abc1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "235311000001105",
"desc": "Ovysmen 500microgram/35microgram tablets (Janssen-Cilag Ltd)",
"form": "Oral tablet",
"vpid": "41877411000001103",
"source": "dmd",
"vtm_id": "775868007",
"strength": "500 microgram",
"substance": "Ethinylestradiol + Norethisterone",
"ingredient": "Norethisterone",
"supplier_code": "2422501000001106"
}See everything about ethinylestradiol + norethisterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.